New: Please Join us on Facebook! Death from Ritalin
The Truth Behind ADHD
Share with your Facebook Friends  

National Alliance against Mandated Mental Health
Screening and Psychiatric Drugging of Children
 Share
 
 
Children's Deaths Caused From ADD & ADHD Drugs
A special savings for anybody who orders Focus Formula either through our website or one of our facebook links. Enter the promo code: SAV20FOCUS to receive a 20% discount and free shipping on any size order.
ADHD Help
Advertising
A-Z Content
Education Articles
Testimonials
Panasonic Massage
Chair Divisio
n
Drug Information
We have 3 Stand
Alone Pages Below

1. Alternative
Therapies

2. Homeopathy

3. Therapeutic
Boarding Schools

We have 10 National Directories Below
Allergists
Chiropractic Neurologist
Chiropractors
Hearing Specialists
Holistic Medical Doctors
Learning Centers
Nutritionists
Osteopathic Physicians
Speech and Language
Vision Specialists
Relevant Sites
 Dr. Fred Baughman Jr. MD, he has been a adult & child neurologist, in private practice, for 35 years
Block Center
Wildest Colts
Gifted Children
Methylphenidate
Annie Armen Live
Peter Breggin, M.D.
Report Site Bugs. Email
web-admin@ritalindeath.com

FDA Talk Paper Strattera

The Food and Drug Administration is advising health care professionals about a new warning for Strattera.

T04-60
December 17", default", 2004

Media Inquiries: 301-827-6242
Consumer Inquiries: 888-INFO-FDA

New Warning for Strattera

The Food and Drug Administration (FDA) is advising health care professionals about a new warning for Strattera, a drug approved for attention deficit hyperactivity disorder (ADHD) in adults and children. The labeling is being updated with a bolded warning about the potential for severe liver injury following two reports (a teenager and an adult) in patients who had been treated with Strattera for several months, both of whom recovered.

The labeling warns that severe liver injury may progress to liver failure resulting in death or the need for a liver transplant in a small percentage of patients. The labeling also notes that the number of actual cases of severe liver injury is unknown because of under-reporting of post-marketing adverse events.

The bolded warning indicates that the medication should be discontinued in patients who developed jaundice (yellowing of the skin or whites of the eyes) or laboratory evidence of liver injury.

Strattera has been on the market since 2002 and has been used in more than 2 million patients. In clinical trials of 6000 patients, no signal for liver problems (hepatotoxicity) had emerged.

FDA has asked the manufacturer to add a bolded warning about severe liver injury to the labeling. Eli Lilly has agreed to alert health care professionals about the new information in a Dear Health Professional letter. The company will also update the patient package insert with information about the signs and symptoms of liver problems, which include:

  • Pruritus (Itchy skin)
  • Jaundice
  • Dark urine
  • Upper right-sided abdominal tenderness
  • Or unexplained “flu-like” symptoms

Health care professionals are encouraged to report any unexpected adverse events associated with Strattera directly to Eli Lilly, Indianapolis, Ind., at 1800-LillyRx or to the FDA MedWatch program at 1800-FDA-1088. The MedWatch form is available online at http://www.fda.gov/medwatch/safety/3500.pdf for download by mail (or fax, 1800-FDA-0178) to MedWatch, HFD-410, FDA, 5600 Fishers Lane, Rockville, Md. 20857.

© 2001-2010 National Alliance against Mandated Mental Health Screening & Psychiatric Drugging of Children. All rights reserved.

Home / About Us / Content / Mission / ADHD Help / Advertising / ADHD Message Board

 

hosted by outflow technologies providing business solutions to results through technology solutions.

 

Don't let psychiatry use their Crystal diagnosis ball on your child!
If you are being harassed to medicate your child for ADHD?
Tell Them Where To Go www.RitalinDeath.com

 

Disclaimer